←BACK

Research Article

 

Zinc Oxide Nanoparticles and Nanorods as Antimicrobial Agents: Particle Size Influence

 

Araa Mebdir Holi 1*, Sadiyha Yasir Offi Al-Jubory 2

 

1 Department of Physics, College of Education, University of Al-Qadisiyah, Al-Diwaniyah, Al-Qadisiyah, 58002, Iraq.

2 Department of Agricultural Biotechnology, College of Biotechnology, University of Al-Qadisiyah, Al-Diwaniyah, Al-Qadisiyah, 58002, Iraq.

 

* Corresponding author. E-mail: araa.holi@qu.edu.iq; Tel.: +9647823145910;

 

Received: Nov. 11, 2019; Accepted: Dec. 10, 2019; Published: Dec. 11, 2019

 

Citation: Araa Mebdir Holi, Sadiyha Yasir Offi Al-Jubory, Zinc Oxide Nanoparticles and Nanorods as Antimicrobial Agents: Particle Size Influence. Nano Biomed. Eng., 2019, 11(4): 375-380.

DOI: 10.5101/nbe.v11i4.p375-380.

 

Abstract

The aim of this study is to find out about the antibacterial activity of a variety of ZnO nanostructures, along with their derivative nanoparticles (ZnO NPs) and nanorods (ZnO NRs) against numerous clinic strains of Gram-negative Escherichia coli (E. coli), Salmonella typhi (S. typhi), Pseudomonas aeruginosa (P. aeruginosa) as well as Gram-positive Streptococcus pneumonia (Strept. pneumonia) bacteria. ZnO NPs and ZnO NRs were efficiently synthesized by using sol-gel and hydrothermal strategies, respectively. Various properties, consisting of the morphology, structure and optical, had been described by using field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD) as well as ultraviolet-visible (UV-Vis) spectroscopy analysis. This check was performed in Mueller-Hinton agar. The impact of different particle sizes and morphologies of ZnO nanomaterials on the growth of bacteria was measured. In the antibacterial assay, each type of ZnO nanostructure showed effective inhibition. The findings showed that ZnO NRs exhibited more efficient antibacterial activity than that of ZnO NPs agents. This was once the case for both Gram-positive and Gram-negative bacteria. Hence, the study indicated that the antibacterial of ZnO NRs against Strept. Pneumonia was similar to those for S. typhi. However, depending on the particle size effect of ZnO nanostructure, it was found that ZnO NPs showed much less antibacterial activity towards S. typhi than ZnO NRs did.

 

Keywords: ZnO nanoparticles; ZnO nanorods; Particle size; Antibacterial activity.

 

Introduction

As well known in scientific fields, zinc oxide (ZnO) is a metal oxide with a wide variety of applications in various fields like optics, piezoelectricity, sensing of gas and magnetics. One of the key features of zinc oxide nanostructures is its high catalytic effectiveness, powerful adsorption ability as well as its widespread utilization in sunscreen manufacture [1]. The nanoparticles of zinc oxide, i.e. ZnO NPs, have been globally synthesized due to these convenient properties, justifying their utilization in many diverse fields, including nano diagnostics [2, 3], nanomedicine [4, 5], antimicrobials [6], and immune toxicity [7]. ZnO NPs have gotten noteworthy attention because of their additional usual ultraviolet (UV) filtering characteristic, antibacterial and high catalytic activities, photochemical antifungal. Moreover, it is a provocative material for applications in gadgets, photonics, acoustics, photovoltaic and photodetectors [8]. Most significant properties of ZnO have been stated in the work by Abd Elhady [9], where is was inferred that ZnO nanorods (ZnO NRs) had UV protection phenomena and antibacterial activities. A various, low-cost, easy, and considerable of techniques have been utilized to prepare ZnO in distinct morphologies and sizes for diverse applications, such as oxidation of metallic zinc powder [10], sol-gel method [11], pulsed laser deposition [12], hydrothermal synthesis [13], chemical vapor deposition [14], electrodeposition [15], and a sputtering method [16]. The antimicrobial activity of zinc oxide nanoparticles has been studied by various researchers [17–19 ]. But we used two ZnO nanostructures (nanoparticles and nanorods) in the present study to investigate the impact of particle size and morphology on antimicrobial performance. Therefore, ZnO has been put under the spotlight lately due to its easimess to prepare and its antimicrobial and antifungal processes even with lower concentrations. These features make it feasible for various thin coating applications as well [20]. As claimed via the U.S. Food and Drug Administration (FDA) (21CFR182.8991), ZnO is dubbed “generally documented as safe” (GRAS). Further, they have been shown to possess a diverse set of antibacterial processes against Gram-positive and -negative bacteria, comprising predominant foodborne pathogens such as Salmonella, Escherichia coli O157: H7, and Staphylococcus aureus [21, 22]. Utilization of antibiotics poses many facet effects, some of which consist of a rise in bacterial resistance [23, 24]. Due to the aforementioned details, the current study sought to check the inhibitory impact of ZnO NPs and ZnO NRs towards bacteria.

 

Experimental

Preparation of ZnO nanoparticles and ZnO nanorod arrays

Sol-gel approach was utilized to set up zinc oxide nanoparticles through mixing 0.1 M of ethanolic solution of zinc acetate alongside with 0.1 M of diethanolamine. In order to nurture a homogeneous and secure colloid solution, the mixture was stirred at 60 C for 30 min. Afterward, it was left to ensure getting aging overnight. Furthermore, hydrothermal manner was used to prepare zinc oxide nanorods. It was the subsequent method to put together zinc oxide nanoparticles by using mixing an aqueous solution of 0.04 M zinc nitrate Zn(NO3)2 and 0.04 M hexamethylenetetramine (HMTA). The hydrothermal method was executed at the temperature of 90 with the employment of a digital oven and constant increase time of 4 h.

 

Antibacterial

Antibacterial activity of zinc oxide nanoparticles and nanorods was examined against hospital strain of Gram-negative E. coli, S. typhi, P. aeruginosa as well as Gram-positive Strept. pneumonia bacteria. These bacteria were received from the Diwaniyah Teaching Hospital and ensured to be diagnostic in the University of Al-Qadisiyah/College of Biotechnology/Iraq. Strains were maintained on nutrient agar for further study.

 

Agar well diffusion assay

The Agar well diffusion approach was utilized to filter the antibacterial endeavor of the synthesized ZnO NPs and ZnO NRs. Wells that had been constructed using a sterile cork borer (6 mm) bored into the Mueller-Hinton Agar (Himedia). Bacterial suspensions were organized with a turbidity of 0.5 McFarland standards (cell density =1 × 108 CFU/Ml) and 100 µL from suspension were swabbed onto the petri dish. The wells were filled with 100 µL ZnO NPs and ZnO NRs from a range of concentrations of 25, 50, 75, 100% by means of micropipette and plates. Next, they were incubated at 37 C for 24 h. The antibacterial activity was estimated by calculating the inhibition zone of the check microorganisms. All the exams were performed in triplicates underneath sterile condition. Gentamicin was once utilized as an advantageous control.

 

Characterizations

The crystallite structures of zinc oxide nanoparticles and nanorods were investigated using X-ray diffractometer (XRD) (Panalytical X’Pert Pro) by using CuKα radiation (λ = 1.54 Å) at 40 kV and 40 mA. Moreover, the samples’ morphology was examined through field emission scanning electron microscopy (FESEM) analysis (JEOL JSM-7600F). Next, the absorbance spectra of the equipped samples were tested by Perkin Elmer Lambda 20 UV-Visible spectrophotometer.

 

Results and Discussion

XRD analysis

Fig. 1 illustrates the XRD results for ZnO nanoparticles and nanorods which were heat-treated using indium tin oxide (ITO) glass substrates. Each sample’s peaks may be indexed as pure zinc oxide wurtzite structure [JCPDS: 00-003-0888]. In addition to these peaks, only ITO peaks [JCPDS: 01-089-4598] that belongs to substrates were observed. Starting of the X-ray line broadening of zinc oxide nanoparticles contrasted with ZnO nanorods, the crystallization sizes were obtained using D = 0.94 λ/ β cosθ: where λ is the X-ray wavelength, θ is the Bragg angle, and β is the full width at half maximum (FWHM)) of the diffraction peak which was 19.1 nm, 22.2 nm, respectively. The rise of (002) peak for zinc-oxide samples exhibiting anisotropic behavior could be observed in Fig. 1(a) and (b) which confirmed that the suitable orientation of both samples was in the c-axis direction.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\2019\11(4)\8 NBE-2019-0068\fig\amht1.jpg

Fig. 1 XRD diffractogram of (a) ZnO NPs and (b) ZnO NRs.

 

FESEM images

Multiple morphologies of zinc oxide nanoparticles and nanorods were made quite apparent, as shown in Fig. 2 displaying FESEM images. Moreover, the mean samples' particle size was located to be 20±5 nm, while for ZnO NRs, the mean length was observed to be 700±50 nm and the diameter to be 60±5 nm. As expected, surface area of the ZnO NRs was found to be much greater than that of ZnO NPs, which is apparent in Fig. 2(b). Additionally, the particle size values of both ZnO morphologies could be clearly observed.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\2019\11(4)\8 NBE-2019-0068\fig\amht2.jpg

Fig. 2 FESEM images of (a) ZnO NPs (top view) and (b) ZnO NRs (top view), with inset image of cross sectional.

 

Ultraviolet–visible spectrum

The plot of absorbance spectra for both zinc oxide nanoparticles and nanorods are displayed in Fig. 3. It could be noted that the absorbance edge shifted a little towards longer wavelengths. Thus, it could be inferred that the absorbance of materials was influenced by particle size. The absorbance spectra showed absorption peaks of ZnO nanoparticles and nanorods at wavelengths of 387 nm and 393 nm, respectively, which could be attributed to the fundamental band-gap of ZnO (as shown in the inset Fig. 3) owing to the transition of electrons from the valence band (VB) to the conduction band (C-B).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\2019\11(4)\8 NBE-2019-0068\fig\amht3.jpg

Fig. 3 UV-Vis spectra and band gap energy curves (shown in an inset of the figure) of (a) ZnO NPs and (b) ZnO NRs.

 

Antimicrobial activity

The antibacterial impact of ZnO (NPs and NRs) was gauged via obtaining the zone of inhibition (displayed in Table 1) versus the studied pathogenic strains. Findings showed that zinc oxide nanoparticles and nanorods exhibited effective antibacterial activity for all strains tested. In general, the findings illustrated that the inhibitory effect of zinc oxide nanoparticles and nanorods rose proportionally with higher concentrations. The bacteria tested exhibited higher sensitivity towards the synthesized zinc oxide nanoparticles and nanorods (Fig. 4 and 5). All the tested bacteria were found to be relatively more sensitive to zinc oxide nanoparticles and nanorods when compared to antibiotics. Similar findings were shown by Fair and Tor [25], where it was shown that the synthesized zinc oxide nanoparticles exhibited improved antimicrobial activities than synthetic drugs did for Gram-positive and -negative bacteria. The findings have confirmed that the small size of nanoparticles is supporting the ease of entering microbial cell membrane and thereby allowing inhibition mechanisms to activate within the cell [26]. It may also be explained by the involvement of reactive oxygen species (ROS) production [27, 28], and accumulation of nanoparticles within the cytoplasm or outer membranes [29, 30], disruption of the cell membrane and oxidative stress [31]. Findings illustrate that Gram-positive bacteria (Strept. pneumoniae) exhibited higher sensitivity to zinc oxide nanoparticles and nanorods than Gram-negative bacteria. Another explanation may additionally be due to the differing nature of surface membranes for the range of bacteria current [32]. The previous work results exhibited that the antibacterial activity of ZnO NPs increased when sizes of the particle were small with high concentrations based on the time effect. Additionally, ZnO nanorods were observed to have been further effective than ZnO nanoparticles. One clarification for this finding might be because of antibacterial impact contingent upon some parameters, for example, particle size, morphology, surface functionality, and fabrication, that has resulted from the large of the surface area of ZnO NRs compared with ZnO NPs. Because of the increasing of touching the surface area that is a significant condition for the effects of nanoparticles shapes [33, 34], consequently, the functional activity of nanoparticles has been strongly influenced by their size. Based on this, the antimicrobial activity of ZnO on bacteria has been enhanced with a diminution of particle size [35, 36]. This used to be interpreted due to the fact of an excess in the surface area to volume, which resulted in the increment reactivity of ZnO surface in nanometer-size. Previous studies [37-39] reported that aqueous suspensions of small nanoparticles of ZnO produced improved levels of reactive oxygen species, particularly hydroxyl radicals with the accumulation of nanoparticles. It may additionally be concluded from the consequence that ZnO NPs and ZnO NRs are well contenders for performing as antibacterial agents for each Gram-positive and Gram-negative bacterium. Based on that, antimicrobial casings are of significant attention for safeguard of the surfaces, because of the existence of microorganisms on superficies in the environment can diffuse diseases [40].

 

Table 1 Antimicrobial activity of ZnO NRs and ZnO NPs against different bacteria. Diameter of inhibition zone is mm. G: Gentamycin.

Inhibition zone diameter (mm)

Sample

Strept. pneumonia.

P. aeruginosa

S. typhi

E. coli

29

11

0.0

10

25% ZnO NPs

29

16

0.0

12

50% ZnO NPs

30

18

14

14

75% ZnO NPs

30

17

15

23

100% ZnO NPs

12

11

12

13

25% ZnO NRs

29

16

30

15

50% ZnO NRs

30

16.5

30

18

75% ZnO NRs

40

20

40

30

100% ZnO NRs

22

17

17

20

G

 

 

 

 

 

 

 

 

 

 

 

 

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\2019\11(4)\8 NBE-2019-0068\fig\amht4.jpg

Fig. 4 Antibacterial activity of ZnO NPs against (a) E. coli, (b) Strept. Pneumonia, (c) S. typhi, and (d) P. aeruginosa, at different concentrations. G: Antibiotic (Gentamycin); DIW: Deionize water.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\2019\11(4)\8 NBE-2019-0068\fig\amht5.jpg

Fig. 5 Antibacterial activity of ZnO NRs against (a) E. coli, (b) S. typhi, (c) P. aeruginosa, and (d) Strept. Pneumonia at different concentrations. G: Antibiotic (Gentamycin); DIW: Deionize water.

 

Conclusions

The multitude of antibacterial activity for zinc oxide nanomaterials possessing various morphology was highlighted in the current study. The antibacterial activity of ZnO nanorods was found to be greater than their nanoparticle counterparts. Variations in antibacterial activity against S. typhi was found to be commensurate to those against E. coli. Nevertheless, when considering the particle size impact on impedance microbiology, Letch-antibacterial activity was found to be much less than its worth and closer to S. typhi. Hence, the occurrence of antibacterial activity may need to be defined via the generation of H2O2 from the surface of ZnO.

 

Acknowledgements

We thank the University of Al-Qadisiyah/ College of Education and College of Biotechnology / Ministry of Higher Education and Scientific Research of Iraq for finical supportfor this study. Special thanks are extended to Diwaniyah Teaching Hospital.

 

References

  1. G. Sangeetha, R. Sivaraj, and V. Rajendran, Green synthesized ZnO nanoparticles against bacterial and fungal pathogens. Progress in Natural Science: Materials International, 2012, 22: 693-700.
  2. J. Pragati, P. Khatri, and J.S. Rana, Green synthesis of zinc oxide nanoparticles using flower extract of Nyctanthes arbor-tristis and their antifungal activity. Journal of King Saud University-Science, 2018, 30: 168-175.
  3. R. Kimia, M. Etemadzade, R. Farhoudi, et al., Fe3+-EDTA-zinc oxide nano-diagnostics: Synthesis and in vitro cellular evaluation. An International Peer Reviewed Open Access Journal for Rapid Publication,  2017: 445.
  4. J. Jinhuan, J. Pi, and J. Cai, The advancing of zinc oxide nanoparticles for biomedical applications. Bioinorganic chemistry and applications, 2018, 2018.
  5. K.I. Bogutska, Y.P. Sklyarov, and Y.I. Prylutskyy, Zinc and zinc nanoparticles: biological role and application in biomedicine. Ukrainica Bioorganica Acta, 2013, 1: 9-16.
  6. K. Rajesh, A. Umar, G. Kumar, et al., Antimicrobial properties of ZnO nanomaterials. A review Ceramics International, 2017, 43: 3940-3961.
  7. K. Cheol-Su, H.-D. Nguyen, R. M. Ignacio, et al., Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge. International Journal of Nanomedicine, 2014, 9: 195.
  8. P. Uikey, K. Vishwakarma, Review of zinc oxide (ZnO) nanoparticles applications and properties. International Journal of Emerging Technology in Computer Science & Electronics, 2016, 21: 239.
  9. M.M. Abd Elhady, Preparation and characterization of chitosan/zinc oxide nanoparticles for imparting antimicrobial and UV protection to cotton fabric. International Journal of Carbohydrate Chemistry, 2012, 2012.
  10. S. Noothongkaew, S. Pukird, W. Sukkabot, et al., Zinc oxide nanostructures synthesized by thermal oxidation of zinc powder on Si substrate. Applied Mechanics and Materials, 2013, 328: 710-714.
  11. A.M. Holi, Z. Zainal, Z.A. Talib, et al., Effect of hydrothermal growth time on ZnO nanorod arrays photoelectrode performance. Optik, 2016, 127: 11111-11118.
  12. Y.Y. Villanueva, D.R. Liu, and P.T. Cheng, Pulsed laser deposition of zinc oxide. Thin Solid Films, 2006, 501: 366-369.
  13. J. Zhang, T. Liu, Y. Zhang, et al., Hydrothermal synthesis and growth mechanisms of different ZnO nanostructures and their gas-sensing properties. Journal of Materials Science: Materials in Electronics, 2015, 26: 1347-1353.
  14. Z. Chen, K. Shum, T. Salagaj, et al., ZnO thin films synthesized by chemical vapor deposition. Proceedings of the 2010 IEEE Long Island Systems, Applications and Technology Conference, 2010: 1-6.
  15. A. Goux, T. Pauporté, J. Chivot, et al., Temperature effects on ZnO electrodeposition. Electrochimica Acta, 2005, 50: 2239-2248.
  16. T. Shimomura, D. Kim, and M. Nakayama, Optical properties of high-quality ZnO thin films grown by a sputtering method. Journal of Luminescence, 2005, 112: 191-195.
  17. O. Yamamoto, Influence of particle size on the antibacterial activity of zinc oxide. International Journal of Inorganic Materials, 2001, 3: 643-646.
  18. A. Sirelkhatim, S. Mahmud, A. Seeni, et al., Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Letters, 2015, 7: 219-242.
  19. V. Tiwari, N. Mishra, K. Gadani, et al., Mechanism of anti-bacterial activity of zinc oxide nanoparticle against carbapenem-resistant Acinetobacter baumannii. Frontiers in Microbiology, 2018, 9: 1218.
  20. E.P.J. Perez, N.D.F. Soares, J.S.D.R. Coimbra, et al., Zinc oxide nanoparticles: synthesis, antimicrobial activity and food packaging applications. Food and Bioprocess Technology, 2012, 5 :1447-1464.
  21. Y. Liu, L. He, A. Mustapha, et al., Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157: H7. Journal of Applied Microbiology, 2009, 107: 1193-1201.
  22. S.R. Senthilkumar, T. Sivakumar, Green tea (Camellia sinensis) mediated synthesis of zinc oxide (ZnO) nanoparticles and studies on their antimicrobial activities. Int. J. Pharm. Pharm. Sci., 2014, 6: 461-465.
  23. B. Fisher, R.P. Harvey, and P.C. Champe, Lippincott's illustrated reviews: Microbiology. Lippincott's illustrated reviews series. Lippincott Williams & Wilkins, 2007: 367-392.
  24. F. Baquero, M.T. Coque, and F. Cruz, Ecology and evolution as targetsthe need for novel Eco-Evo drugs and strategies to fight antibiotic resistance. Antimicrob. Agents Ch., 2011, 55: 3649-3660.
  25. R.J. Fair, Y. Tor, Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry, 2014, 6: PMC-S14459.
  26. Q.H. Yu, Z.S. Wang, and Q. Yang, Ability of Lactobacillus to inhibit enteric pathogenic bacteria adhesion on Caco-2 cells. World J. Microbiol. Bio. Technol., 2012, 27: 881-886.
  27. M.S. Jabir, U.M. Nayef, A. Kadhim, et al., Polyethylene glycol-functionalized magnetic (Fe3O4) nanoparticles: A novel DNA-mediated antibacterial agent. Nano Biomedicine & Engineering, 2019, 11: 18-27.
  28. M.S. Jabir, A.A. Taha, and U.I. Sahib, Linalool loaded on glutathione-modified gold nanoparticles: A drug delivery system for a successful antimicrobial therapy. Artificial Cells, Nanomedicine, and Biotechnology, 2018, 46: 345-355.
  29. Y.N. Slavin, J. Asnis, U.O. Häfeli, et al., Metal nanoparticles: understanding the mechanisms behind antibacterial activity. Journal of Nanobiotechnology, 2017, 15: 65.
  30. K.S. Siddiqi, A. Ur Rahman, and A. Husen, Properties of zinc oxide nanoparticles and their activity against microbes. Nanoscale research Letters, 2018, 13: 141.
  31. Y. Xie, Y. He, P.L. Irwin, et al., Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl. Environ. Microbiol, 2011, 77: 2325-2331.
  32. J.T. Seil, T.J. Webster, Antimicrobial applications of nanotechnology: Methods and literature. International Journal of Nanomedicine, 2012, 7: 2767.
  33. B. Sadeghi, M. Jamali, S. Kia, et al., Synthesis and characterization of silver nanoparticles for antibacterial activity. International Journal of Nano Dimension, 2010, 1: 119-124.
  34. V.V. Kumar, S.P. Anthony, Antimicrobial studies of metal and metal oxide nanoparticles. Surface chemistry of nanobiomaterials. William Andrew Publishing, 2016: 265-300.
  35. N. Jones, B. Ray, K.T. Ranjit, et al., Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiology Letters, 2008, 279: 71-76.
  36. L. Zhang, Y. Jiang, and Y. Ding, Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). Journal of Nanoparticle Research, 2007, 9: 479–489.
  37. T. Ohira, O. Yamamoto, Y. Iida, et al., Antibacterial activity of ZnO powder with crystallographic orientation. Journal of Materials Science: Materials in Medicine, 2008, 19: 1407-1412.
  38. G. Applerot, A. Lipovsky, R. Dror, et al., Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS-mediated cell injury. Advanced Functional Materials, 2009, 19: 842-852.
  39. K.R. Raghupathi, R.T. Koodali, et al., Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir, 2011, 27: 4020-4028.
  40. K.H. Tam, A.B. Djurišić, C.M.N. Chan, et al., Antibacterial activity of ZnO nanorods prepared by a hydrothermal method. Thin Solid Films, 2005, 516: 6167-6174.

 

Copyright© Araa Mebdir Holi, Sadiyha Yasir Offi Al-Jubory. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Nano Biomedicine and Engineering.

Copyright © Shanghai Jiao Tong University Press